David Ryan - Bioharvest Sciences S Relations
| CNVCFDelisted Stock | USD 5.13 0.07 1.35% |
Insider
David Ryan is S Relations of Bioharvest Sciences
| Age | 56 |
| Phone | 604 622 1186 |
| Web | https://www.bioharvest.com |
David Ryan Latest Insider Activity
Tracking and analyzing the buying and selling activities of David Ryan against Bioharvest Sciences otc stock is an integral part of due diligence when investing in Bioharvest Sciences. David Ryan insider activity provides valuable insight into whether Bioharvest Sciences is net buyers or sellers over its current business cycle. Note, Bioharvest Sciences insiders must abide by specific rules, including filing SEC forms every time they buy or sell Bioharvest Sciences'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
David Ryan over two weeks ago Acquisition by David Ryan of 707 shares of Affiliated Managers subject to Rule 16b-3 | ||
David Ryan over six months ago Disposition of 370 shares by David Ryan of Affiliated Managers subject to Rule 16b-3 |
Bioharvest Sciences Management Efficiency
The company has return on total asset (ROA) of (0.5264) % which means that it has lost $0.5264 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (63.6438) %, meaning that it generated substantial loss on money invested by shareholders. Bioharvest Sciences' management efficiency ratios could be used to measure how well Bioharvest Sciences manages its routine affairs as well as how well it operates its assets and liabilities.Bioharvest Sciences has accumulated 3.97 M in total debt with debt to equity ratio (D/E) of 1.62, which is about average as compared to similar companies. Bioharvest Sciences has a current ratio of 0.68, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Bioharvest Sciences until it has trouble settling it off, either with new capital or with free cash flow. So, Bioharvest Sciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Bioharvest Sciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Bioharvest to invest in growth at high rates of return. When we think about Bioharvest Sciences' use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| John JankovichBesan | Avi Ltd ADR | 55 | |
| William Drury | Artisan Consumer Goods | 61 | |
| David Akers | The A2 Milk | N/A | |
| Mark Sherwin | The A2 Milk | N/A | |
| Hannah Collyer | Premier Foods Plc | N/A | |
| John LaViolette | BioForce Nanosciences Holdings | 62 | |
| Amber Finney | Artisan Consumer Goods | 44 | |
| Armin Bieri | Aryzta AG PK | 59 | |
| Jamie Eichman | Laird Superfood | 46 | |
| Catherine Makin | Avi Ltd ADR | 59 | |
| Martin Huber | Aryzta AG PK | 53 | |
| Andrew Judd | Laird Superfood | N/A | |
| Gabrielle Reece | Laird Superfood | N/A | |
| Paul Thompson | Premier Foods Plc | N/A | |
| Laird Hamilton | Laird Superfood | 60 | |
| Rhona Shakespeare | Aryzta AG PK | 49 | |
| Alexander Whitehouse | Premier Foods Plc | N/A | |
| Amanda Hart | The A2 Milk | N/A | |
| Gaynor Poretti | Avi Ltd ADR | 54 | |
| Marcus Opitz | Aryzta AG PK | 62 | |
| Jane Xu | The A2 Milk | N/A | |
Management Performance
| Return On Equity | -63.64 | |||
| Return On Asset | -0.53 |
Bioharvest Sciences Leadership Team
Elected by the shareholders, the Bioharvest Sciences' board of directors comprises two types of representatives: Bioharvest Sciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bioharvest. The board's role is to monitor Bioharvest Sciences' management team and ensure that shareholders' interests are well served. Bioharvest Sciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bioharvest Sciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Zaki Rakib, CoFounder Chairman | ||
| BCom BComm, Chief Officer | ||
| Brian Cornblatt, Chief Officer | ||
| David Ryan, S Relations | ||
| Yochi Hagay, CTO CoFounder | ||
| Ilan Sobel, Chief Officer |
Bioharvest Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Bioharvest Sciences a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -63.64 | |||
| Return On Asset | -0.53 | |||
| Profit Margin | (2.69) % | |||
| Operating Margin | (2.45) % | |||
| Current Valuation | 106.97 M | |||
| Shares Outstanding | 460.72 M | |||
| Shares Owned By Insiders | 35.15 % | |||
| Price To Book | 91.96 X | |||
| Price To Sales | 28.13 X | |||
| Revenue | 2.1 M |
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Bioharvest Sciences information on this page should be used as a complementary analysis to other Bioharvest Sciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Other Consideration for investing in Bioharvest OTC Stock
If you are still planning to invest in Bioharvest Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bioharvest Sciences' history and understand the potential risks before investing.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |